Cargando…

The gut microbiome in patients with chronic lymphocytic leukemia

Detalles Bibliográficos
Autores principales:	Faitová, Tereza, Svanberg, Rebecka, da Cunha-Bang, Caspar, Ilett, Emma E., Jørgensen, Mette, Noguera-Julian, Marc, Paredes, Roger, MacPherson, Cameron R., Niemann, Carsten U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425300/ https://www.ncbi.nlm.nih.gov/pubmed/35548869 http://dx.doi.org/10.3324/haematol.2021.280455

Ejemplares similares

P599: ACALABRUTINIB IMPROVES INNATE IMMUNE FUNCTION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
por: Teglgaard, Rebecca, et al.
Publicado: (2023)

Pre-Transplant Prediction of Acute Graft-versus-Host Disease Using the Gut Microbiome
por: Zargari Marandi, Ramtin, et al.
Publicado: (2022)

Gut microbiome comparability of fresh-frozen versus stabilized-frozen samples from hospitalized patients using 16S rRNA gene and shotgun metagenomic sequencing
por: Ilett, Emma E., et al.
Publicado: (2019)

Metabolic Potential of the Gut Microbiome Is Significantly Impacted by Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
por: Jørgensen, Mette, et al.
Publicado: (2022)

Targeting the tumor microenvironment in chronic lymphocytic leukemia
por: Svanberg, Rebecka, et al.
Publicado: (2021)

2569. The Gut Microbiome and Acute Graft vs. Host Disease Risk in Hematopoietic Stem Cell Transplantation Recipients
por: Ilett, Emma E, et al.
Publicado: (2019)

Healthcare Utilization and Comorbidity in Chronic Lymphocytic Leukemia
por: Rotbain, Emelie C, et al.
Publicado: (2021)

315. An Interpretable Machine Learning Model Using The Gut Microbiome to Predict Clinical E. faecium Infection in Human Stem-Cell Transplant Recipients
por: Zargari Marandi, Ramtin, et al.
Publicado: (2023)

Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients
por: Svanberg, Rebecka, et al.
Publicado: (2022)

Author Correction: Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients
por: Svanberg, Rebecka, et al.
Publicado: (2023)

Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning
por: Zucco, Adrian G., et al.
Publicado: (2022)

The Danish National Chronic Lymphocytic Leukemia Registry
por: da Cunha-Bang, Caspar, et al.
Publicado: (2016)

IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: a Danish nationwide population-based study
por: Rotbain, Emelie Curovic, et al.
Publicado: (2020)

Deep targeted sequencing of TP53 in chronic lymphocytic leukemia: clinical impact at diagnosis and at time of treatment
por: Brieghel, Christian, et al.
Publicado: (2019)

Risk factors associated with Richter’s transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort study
por: Hleuhel, Mariam Hussein, et al.
Publicado: (2019)

CLL-IPI applied in Binet A CLL: a nationwide cohort study
por: Rotbain, Emelie C., et al.
Publicado: (2022)

Patients with CLL have a lower risk of death from COVID-19 in the Omicron era
por: Niemann, Carsten U., et al.
Publicado: (2022)

Improved survival for patients diagnosed with chronic lymphocytic leukemia in the era of chemo-immunotherapy: a Danish population-based study of 10455 patients
por: da Cunha-Bang, C, et al.
Publicado: (2016)

Subcellular Compartments Interplay for Carbon and Nitrogen Allocation in Chromera velia and Vitrella brassicaformis
por: Füssy, Zoltán, et al.
Publicado: (2019)

P603: INFECTIONS BEFORE AND DURING IMMUNOGLOBULIN REPLACEMENT THERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA.
por: Brieghel, Christian, et al.
Publicado: (2023)

S144: BTK AND BCL-2 ACTIVITY AT BASELINE PREDICTS MRD STATUS FOR CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH IBRUTINIB + VENETOCLAX IN THE HOVON 141/VISION TRIAL
por: Urban, Aleksandra, et al.
Publicado: (2023)

Idelalisib and caffeine reduce suppression of T cell responses mediated by activated chronic lymphocytic leukemia cells
por: Hock, Barry D., et al.
Publicado: (2017)

Pre-diagnostic trajectories of lymphocytosis predict time to treatment and death in patients with chronic lymphocytic leukemia
por: Andersen, Michael Asger, et al.
Publicado: (2022)

Balances: a New Perspective for Microbiome Analysis
por: Rivera-Pinto, J., et al.
Publicado: (2018)

S140: IBRUTINIB SENSITIZES CLL CELLS TO VENETOCLAX BY INTERRUPTING TLR9-INDUCED CD40 UPREGULATION AND PROTEIN TRANSLATION
por: Kielbassa, Karoline, et al.
Publicado: (2023)

Systematic Literature Review of Economic Evaluations of Treatment Alternatives in Chronic Lymphocytic Leukemia
por: Lorenzovici, László, et al.
Publicado: (2023)

Gut microbiome in hemodialysis patients treated with calcium acetate or treated with sucroferric oxyhydroxide: a pilot study
por: Merino-Ribas, Ana, et al.
Publicado: (2021)

Probiotic effects on immunity and microbiome in HIV-1 discordant patients
por: Blázquez-Bondia, Carlos, et al.
Publicado: (2022)

29. Sustained Recovery in Patients Admitted to Hospital With COVID-19
por: Moestrup, Kasper S, et al.
Publicado: (2021)

COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study
por: Niemann, Carsten U., et al.
Publicado: (2022)

Oral microbiome in HIV-associated periodontitis
por: Noguera-Julian, Marc, et al.
Publicado: (2017)

A case of SRSF2 mutation in chronic lymphocytic leukemia
por: Garza, Eduardo, et al.
Publicado: (2016)

Ibrutinib sensitizes CLL cells to venetoclax by interrupting TLR9-induced CD40 upregulation and protein translation
por: Kielbassa, Karoline, et al.
Publicado: (2023)

Characteristics of the gut microbiome in women with gestational diabetes mellitus: A systematic review
por: Rold, Louise Søndergaard, et al.
Publicado: (2022)

PB1915: THE MULTI-FACETED ROLE OF ORAL AND GUT MICROBIOME IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
por: Paziewska, Magdalena, et al.
Publicado: (2023)

Merkel cell carcinoma mimicking transformed chronic lymphocytic leukemia/small lymphocytic lymphoma
por: Bah, Ismael, et al.
Publicado: (2019)

Evolution of the gut microbiome following acute HIV-1 infection
por: Rocafort, Muntsa, et al.
Publicado: (2019)

Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations
por: Wierda, William G., et al.
Publicado: (2021)

Secondary malignancies and survival of FCR‐treated patients with chronic lymphocytic leukemia in Central Europe
por: Kósa, Fruzsina, et al.
Publicado: (2022)

Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV
por: Klausen, Uffe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ll89450uqr8kc7qv77d0rfqc35